28th International Conference on Neuropharmacology and Neurochemistry

                                                      May 22-23, 2023 Vienna, Austria

                   THEME-  Current Scenario and Future Approach in Neuropharmaceutics

One billion individuals worldwide suffer from neurological problems, and a clinical suite at a University of Queensland health research center is prepared to assist solve their mysteries.

Recently opened at UQ's Centre for Clinical Research (UQCCR), the Neurosciences Clinical Research Suite (NCRS) will serve as a hub for scientists, physicians, and other medical specialists to interact with clinical trial participants and discover novel treatments for brain illnesses.

Associate Professor Rob Henderson, a specialist neurologist and clinical researcher at UQCCR, said the Herston Health Precinct suite had been created to help satisfy a rising need and allow them to potentially boost clinical trials.

We cordially invite you to attend the 28th International Conference on Neuropharmacology and Neurochemistry, which will be held on May 22-23, 2023. The conference will be the theme of “Current Scenario and Future Approach in Neuropharmaceutics."

The Neuropharmacology and Neurochemistry conference is a specific discussion to bring innovative methods and also unite renowned Researchers and academicians concerned with neurology, neuroscience, and cognition, as well as Psychiatrist specialists, Public health professionals, Neuroscientists and Specialists to trade about innovative research and innovations. This conference will provide advanced knowledge in Neuropharmacology and Neurochemistry. 

 Neuropharmacology and Neurochemistry

Learning about the brain mechanisms by which medicines affect behaviour and how they disturb cellular activity in the nervous system is known as neurochemistry and neuropharmacology. Behavioral and molecular neuropharmacology are its two main subfields. Neuropsychopharmacology, a branch of behavioural neuropharmacology, focuses on understanding how drugs affect human behaviour, along with the effects of drug dependence and addiction on the brain.

• Pharmacodynamics
• Pharmacokinetics
• Clinical pharmacology
• Pharmacology           

Neurogenesis

The process through which new neurons are created in the brain is known as neurogenesis. When an embryo is growing, neurogenesis is essential, but it also continues in some parts of the brain after birth and throughout life. The mature brain has multiple functionally specialized sections as well as neurons with various structural and connectivity characteristics. For instance, the hippocampus, a part of the brain that is crucial for memory and spatial navigation, includes at least 27 different varieties of neurons

Past Affiliation-  Ronald J. Swatzyna

Dr. Ronald Swatzyna received his Master of Science and Doctorate of Philosophy from The University of Texas Arlington. Currently, he is the Director of Electro-Neurophysiology Research, Director of Neurotherapy at the Tarnow Center for Self-management, and is an associate of Brain Science International. Dr. Swatzyna is a licensed clinical social worker supervisor, board certified in Neurotherapy and biofeedback by the Biofeedback Certification International Alliance (BCIA). 

Dafin F. Muresanu- Professor of Neurology, Senior Neurologist, Chairman of the Neurosciences Department, Faculty of Medicine, University of Medicine and Pharmacy “Iuliu Hatieganu” Cluj-Napoca, President of the Romanian Society of Neurology, President of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN), member of the Academy of Medical Sciences, Romania, secretary of its Cluj Branch. He is also member of 13 scientific international societies (being member of the American Neurological Association (ANA) - Fellow of ANA (FANA) since 2012) and 7 national ones, being part of the executive board of most. Professor Dafin F. Muresanu is a specialist in Leadership and Management of Research and Health Care Systems (specialization in Management and Leadership, Arthur Anderson Institute, Illinois, USA, 1998 and several international courses and training stages in Neurology, research, management and leadership). 

Market Analysis

The global neuroscience market was valued at USD 28.42 billion in 2016 and is expected to expand at a CAGR of 3.1 percent during the forecast period. Ongoing brain mapping research and analysis projects, neuroscience-based projects by government bodies, and technological advances in tools and algorithms used in the neuroscience space are expected to drive market growth. North America was the largest regional market in 2016. The presence of a significant number of neuroscience-based research entities, funding from the government and other organizations, and the availability of well-built healthcare systems, as well as the rising popularity of neurological disorders in the region, are key factors recognized for this large share. When compared to China and Japan, Asia Pacific is expected to be the fastest-growing regional market due to the region's constantly improving healthcare system and the presence of a significant target population

Internationally known experts in the domains of neuropharmacology and neurochemistry, as well as brain researchers, public health professionals, neuroscientists, academic neuroscientists, business researchers, and neuroscholars, will convene at Neuropharmaceutics 2023.

FOR MORE INFORMATION - https://neuropharmaceutics.conferenceseries.com

Alev Bell | Program Director
Neuropharmaceutics 2023
Whatsapp: +447915638336
Email: neuropharmaceutics@meetingsemail.com